The Institute for Molecular Bioscience is committed to using life sciences discovery for disease application and sustainable futures.

We are The University of Queensland’s oldest and largest research institute with a strong track record in working with partners to translate our research to the clinic, for the environment, for policy and for commercial application.

We believe that partnering brings together the skills, facilities and resources for mutual benefit.

Clear, efficient, mutually respectful, the combination of discovery-driven research and solution-focused partnerships creates an environment for innovation and application.

Download our Partnerships with IMB brochure (PDF)

Discovery research for disease application

Our Institute is committed to using life science discoveries to offer disease application and sustainable futures. We are unique in the combination of biomedical, biological, pharmacological and chemical research capabilities. This means that we can take basic science to the point of application. 

Our Research Leaders are some of the most highly-cited researchers in the world. This means they are global leaders of thought, enquiry and investigation. 

Our research strengths and capabilities span biochemistry, genetics, molecular biology, immunology, microbiology, pharmacology, toxicology and pharmaceutics. We work in Centres to support coalition and collaboration across disciplines. Because of this, we are conduit to achieving end solutions and a pipeline to end-use. We value our partners, share a passion for life science discovery and solution-driven research and a mutual respect for the expertise and philosophies of our partners.

World-class facilities, innovations and capabilities

Our research facilities span imaging, computational biology, bioinformatics, genome sequencing and analysis, statistical genetics, chemistry, structural biology and drug discovery and high performance computing. This means, for example, we can identify new biological markers, pathways or influences, determine function and structure, leading to drug design and evaluation. As a result, we have spun out 11 companies, registered more than 66 patents, 104 provisional patents and 16 our licensing agreements.

Access to research students, early career researchers 

The Institute is committed to the employability of our research training students and early career researchers. As importantly, we are committed to ensuring that they are able to contribute to the global knowledge base and economic development of the organization in which they are employed and for national benefit. As such, we believe in the value of industry partnerships, through mentorship, placement or collaboration. As the future of R&D, we are advocates for opportunities that bring them, and us, closer to our partners.

Offsetting the cost of innovation 

By working with the IMB, you access research infrastructure, expertise, global connections and future employment opportunities by working with our research training students and early career researchers. 

In addition to our capabilities and resources, the IMB can work with partners to identify funding opportunities, leveraging State, Federal and international funding schemes to offset the cost of R&D.

Solutions-focused deal-making

IMB works closely with UniQuest, the main commercialisation company of The University of Queensland. They recognise the need to achieve mutually beneficial deals that see UQ researchers work with industries to solve real world problems.

UniQuest considers each collaboration on its own merits and tailors IP ownership and management in consultation with our partners, facilitating competitiveness in the marketplace and identifies flexible and innovative arrangements that allow our partners to achieve their goals.

Gateway to the world

In addition to the research collaborations with other Faculties, Schools and Centres in the University of Queensland, IMB collaborations span the State of Queensland, Australia and the globe. We have over 1,000 collaborations in over 57 countries. We can open the door to a world of expertise, research providers, corporate and government partners to expand the scope and depth of a response to your research needs.

Our partners are wide and diverse. From other academic institutions, to health providers, industry, charities and governments, we triangulate partnerships to find innovative solutions to local, regional and international challenges. 


If you are interested in partnering with IMB, please contact our Partnership Office at


Global Collaborations

UQ is one of the top twenty research institutions in life sciences in the world* (2016 Academic Ranking of World Universities) 

IMB: UQ’s largest life sciences research institute.

IMB Bringing Discovery to Application: 

  • $10 million secured in government and industry funding to find solutions to industry problems
  • IMB partners include health services, non-government agencies, SMEs, local, national and industry partners
  • 11 spinouts
  • 66 patents across 38 patent families in the following research areas:
    • 4 agriculture/industrial biotechnology
    • 6 diagnostics/devices
    • 6 drug discovery tools
    • 22 therapeutics

IMB Enduring Quality

IMB spinout Protagonist listed on the NASDAQ in 2016 and awarded Australian Company of the Year*

*AusBiotech and Johnson and Johnson’s Innovation Industry Excellence Awards